TAI Diagnostics

TAI Diagnostics Overview

Founded 2015
Founded
Status Private
Latest Deal Type Series A
Latest Deal Amount $12.8M
Latest Deal Amount
Investors 5

TAI Diagnostics General Information

Description

Developer of a diagnostic test designed to monitor the health of transplanted organs. The company's test which utilizes cf-dna technology as a direct measurement of organ injury through quantitation of donor-specific cf-dna released into the bloodstream from injured cells of a transplanted organ, enabling physicians to detect rejection early and perform surveillance biopsies at regular intervals caused by a deletion from chromosome 22 at the q11 location.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Primary Office
  • 10101 Innovation Drive
  • Suite 600
  • Milwaukee, WI 53226
  • United States
+1 (414) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TAI Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 30-May-2018 $12.8M 000.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 23-Oct-2015 00.00 00.00 0000 Completed Startup

TAI Diagnostics Cap Table

To view TAI Diagnostics‘s complete cap table, request access >>
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000

TAI Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
Frank Langley Chief Executive Officer & Board Member
Aoy Tomita-Mitchel Ph.D Co-Founder, Chief Scientific Officer & Board Member
Paula North Ph.D Chief Laboratory Officer & Medical Director

TAI Diagnostics Board Members (6)

To view TAI Diagnostics‘s full board member team, request access >>
Name Representing Role Since
Aoy Tomita-Mitchel Ph.D TAI Diagnostics Co-Founder, Chief Scientific Officer & Board Member 000 0000
Frank Langley TAI Diagnostics Chief Executive Officer & Board Member 000 0000
George Arida 30Ventures Board Observer 000 0000
John Fowler Self Board Member 000 0000
John Neis Venture Investors Board Member 000 0000

TAI Diagnostics Investors (5)

To view TAI Diagnostics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
30Ventures Venture Capital Minority 000 0000 000000 0
United Therapeutics Corporation Minority 000 0000 000000 0
Wisconsin Investment Partners Venture Capital Minority 000 0000 000000 0
Venture Investors Venture Capital Minority 000 0000 000000 0
Wisconsin Economic Development Corporation Government Minority 000 0000 000000 0

Ready to get started?

Request a free trial